India may have to wait longer for Pfizer, GSK’s Covid drugs, Health News, ET HealthWorld
There is uncertainty over the availability in India of Pfizer’s antiviral drug Paxlovid and GSK’s monoclonal antibody Sotrovimab (sold under the brand name Xevudy) – two therapies that appear to…
